Suppr超能文献

国际生物样本库与网络综述:成功因素与关键基准

A review of international biobanks and networks: success factors and key benchmarks.

作者信息

Vaught Jim, Kelly Andrea, Hewitt Robert

机构信息

1 Office of Biorepositories and Biospecimen Research (OBBR), National Cancer Institute , National Institutes of Health, Bethesda, Maryland.

出版信息

Biopreserv Biobank. 2009 Sep;7(3):143-50. doi: 10.1089/bio.2010.0003. Epub 2010 Mar 17.

Abstract

Biobanks and biobanking networks are involved in varying degrees in the collection, processing, storage, and dissemination of biological specimens. This review outlines the approaches that 16 of the largest biobanks and biobanking networks in Europe, North America, Australia, and Asia have taken to collecting and distributing human research specimens and managing scientific initiatives while covering operating costs. Many are small operations that exist as either a single or a few freezers in a research laboratory, hospital clinical laboratory, or pathology suite. Larger academic and commercial biobanks operate to support large clinical and epidemiological studies. Operational and business models depend on the medical and research missions of their institutions and home countries. Some national biobanks operate with a centralized physical biobank that accepts samples from multiple locations. Others operate under a "federated" model where each institution maintains its own collections but agrees to list them on a central shared database. Some collections are "project-driven" meaning that specimens are collected and distributed to answer specific research questions. "General" collections are those that exist to establish a reference collection, that is, not to meet particular research goals but to be available to respond to multiple requests for an assortment of research uses. These individual and networked biobanking systems operate under a variety of business models, usually incorporating some form of partial cost recovery, while requiring at least partial public or government funding. Each has a well-defined biospecimen-access policy in place that specifies requirements that must be met-such as ethical clearance and the expertise to perform the proposed experiments-to obtain samples for research. The success of all of these biobanking models depends on a variety of factors including well-defined goals, a solid business plan, and specimen collections that are developed according to strict quality and operational controls.

摘要

生物样本库和生物样本库网络在生物样本的采集、处理、存储和传播方面有着不同程度的参与。本综述概述了欧洲、北美、澳大利亚和亚洲16个最大的生物样本库和生物样本库网络在采集和分发人类研究样本以及管理科学项目以覆盖运营成本方面所采取的方法。许多都是小规模运作,存在于研究实验室、医院临床实验室或病理科的单个或几个冰柜中。较大的学术和商业生物样本库的运作是为了支持大型临床和流行病学研究。运营和商业模式取决于其所在机构和母国的医学和研究使命。一些国家生物样本库通过一个集中的实体生物样本库运作,该样本库接受来自多个地点的样本。其他的则采用“联合”模式,即每个机构都维持自己的样本收集,但同意将其列在一个中央共享数据库中。一些样本收集是“项目驱动”的,这意味着样本被收集和分发以回答特定的研究问题。“通用”样本收集是为了建立一个参考样本库而存在的,也就是说,不是为了满足特定的研究目标,而是为了能够响应各种研究用途的多个请求。这些个体和网络化的生物样本库系统在各种商业模式下运作,通常包含某种形式的部分成本回收,同时至少需要部分公共或政府资金。每个系统都有一个明确的生物样本获取政策,该政策规定了为获取研究样本必须满足的要求,如伦理批准和进行拟议实验的专业知识。所有这些生物样本库模式的成功取决于多种因素,包括明确的目标、坚实的商业计划以及根据严格的质量和操作控制开发的样本收集。

相似文献

1
A review of international biobanks and networks: success factors and key benchmarks.
Biopreserv Biobank. 2009 Sep;7(3):143-50. doi: 10.1089/bio.2010.0003. Epub 2010 Mar 17.
4
A strategic plan for the second phase (2013-2015) of the Korea biobank project.
Osong Public Health Res Perspect. 2013 Apr;4(2):107-16. doi: 10.1016/j.phrp.2013.03.006.
5
Advancing Professionalization of Biobank Business Operations: Performance and Utilization.
Biopreserv Biobank. 2019 Jun;17(3):213-218. doi: 10.1089/bio.2019.0005.
6
Biobanking Comes of Age: The Transition to Biospecimen Science.
Annu Rev Pharmacol Toxicol. 2016;56:211-28. doi: 10.1146/annurev-pharmtox-010715-103246. Epub 2015 Oct 22.
7
Biobank networking and globalisation: perspectives and practices of Australian biobanks.
Aust Health Rev. 2021 Mar;45(2):214-222. doi: 10.1071/AH20063.
8
Advancing Professionalization of Biobank Business Operations: A Worldwide Survey.
Biopreserv Biobank. 2019;17(1):71-75. doi: 10.1089/bio.2018.0079. Epub 2018 Nov 9.
9
The human face of biobank networks for translational research.
Biopreserv Biobank. 2011 Sep;9(3):279-85. doi: 10.1089/bio.2011.0018.
10
Recommendations for a Dutch Sustainable Biobanking Environment.
Biopreserv Biobank. 2021 Jun;19(3):228-240. doi: 10.1089/bio.2021.0011. Epub 2021 May 27.

引用本文的文献

1
Quantifying the impact of biobanks and cohort studies.
Proc Natl Acad Sci U S A. 2025 Apr 22;122(16):e2427157122. doi: 10.1073/pnas.2427157122. Epub 2025 Apr 16.
2
Specimen sharing for epidemic preparedness: Building a virtual biorepository system from local governance to global partnerships.
PLOS Glob Public Health. 2023 Oct 11;3(10):e0001568. doi: 10.1371/journal.pgph.0001568. eCollection 2023.
3
4
Biobanking in the digital pathology era.
Oncol Res. 2022 Aug 31;29(4):229-233. doi: 10.32604/or.2022.024892. eCollection 2021.
6
Standard operating procedures for biobank in oncology.
Front Mol Biosci. 2022 Aug 26;9:967310. doi: 10.3389/fmolb.2022.967310. eCollection 2022.
7
Assessment of Current Practices Across Alzheimer's Disease Research Centers Biorepositories.
Biopreserv Biobank. 2023 Jun;21(3):282-287. doi: 10.1089/bio.2022.0022. Epub 2022 Jul 19.
8
From biobank and data silos into a data commons: convergence to support translational medicine.
J Transl Med. 2021 Dec 4;19(1):493. doi: 10.1186/s12967-021-03147-z.
9
Human OMICs and Computational Biology Research in Africa: Current Challenges and Prospects.
OMICS. 2021 Apr;25(4):213-233. doi: 10.1089/omi.2021.0004. Epub 2021 Apr 1.
10
A high-throughput phenotyping algorithm is portable from adult to pediatric populations.
J Am Med Inform Assoc. 2021 Jun 12;28(6):1265-1269. doi: 10.1093/jamia/ocaa343.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验